Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD)
Authors:
- Shibu P. ThomasSTShibu P. Thomas
- Harpal Singh NandhraHNHarpal Singh Nandhra
- Anand JayaramanAJAnand Jayaraman
- 8 April 2010
- journal article
- review article
- Published by Taylor & Francis in Journal of Mental Health
- Vol. 19 (2) , 168-175
Abstract
Our aim was to review all the evidence of lamotrigine's effectiveness in treatment resistant depression after at least one failed antidepressant trial. We used a systematic search strategy to identify studies that included adults aged 18-65 years with a diagnosis of unipolar depression who had not responded to at least a 4-week course of a recommended dose of an antidepressant. We found only one randomized, double blind study that has been published, showing its effectiveness for treatment-resistant depression. In this study, lamotrigine was found statistically superior to placebo on the CGI scale for severity and improvement; however, it was not on the HAM-D (primary end point) and MADRS scales. There were a number of smaller non RCT's which are included. There is little evidence to guide the use of lamotrigine for depression that has not responded to a course of antidepressants. Treatment-refractory depression continues to be significant mental health problem and large RCT trials are needed to inform clinical practice.Keywords
This publication has 16 references indexed in Scilit:
- Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trialsThe British Journal of Psychiatry, 2009
- Lamotrigine adjunctive treatment in resistant unipolar depression: an open, descriptive studyDepression and Anxiety, 2006
- Lamotrigine Augmentation Strategy for Patients with Treatment-Resistant DepressionCNS Spectrums, 2005
- New drugs, old problems: Revisiting… Pharmacological management of treatment-resistant depressionAdvances in Psychiatric Treatment, 2005
- Lithium augmentation therapy in refractory depression?Update 2002European Archives of Psychiatry and Clinical Neuroscience, 2003
- Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) studyPsychiatric Clinics of North America, 2003
- A Double-Blind, Randomized, Placebo-Controlled Trial of Augmentation With Lamotrigine or Placebo in Patients Concomitantly Treated With Fluoxetine for Resistant Major Depressive EpisodesThe Journal of Clinical Psychiatry, 2003
- Lamotrigine as an Augmentation Agent in Treatment-Resistant DepressionThe Journal of Clinical Psychiatry, 2002
- Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United StatesArchives of General Psychiatry, 1994
- A Population-Based Twin Study of Major Depression in WomenArchives of General Psychiatry, 1992